The Valley Desk

Clinical trial reportJournal for immunotherapy of cancerPublished

Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal for immunotherapy of cancer
Published
Subject terms
Humans; Head and Neck Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Ipilimumab; B7-H1 Antigen; Squamous Cell Carcinoma of Head and Neck; Nivolumab; Immunotherapy; Radiotherapy; Head and neck neoplasms
PubMed ID
37536941
PubMed Central ID
PMC10401226
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal